Aquestive Therapeutics, Inc. (AQST) vs Collegium Pharmaceutical, Inc. (COLL)
- Aquestive Therapeutics, Inc. AQST 3.78 −6.90%
- Collegium Pharmaceutical, Inc. COLL 23.19 +0.04%
Aquestive Therapeutics, Inc. and Collegium Pharmaceutical, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $754.6M against $509.6M — 1.5× the size. Aquestive Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 15.2×. Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 22.6% against 14.3%. Collegium Pharmaceutical, Inc. has the higher net margin (5.93% vs −144.6%) and the higher return on invested capital (7.85% vs 0.00%). Across the 18 metrics below, Collegium Pharmaceutical, Inc. leads on 13 and Aquestive Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | AQST | COLL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 67.04% | 60.02% | 53.94% |
| Operating margin | (97.52%) | 19.48% | 0.00% |
| Net margin | (144.63%) | 5.93% | 0.00% |
| Free cash flow margin | (84.95%) | 40.62% | 0.00% |
| Return on equity | 121.12% | 17.61% | (0.40%) |
| Return on assets | (69.29%) | 2.57% | (3.32%) |
| Return on invested capital | 0.00% | 7.85% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack